enVVeno Medical Corp
About enVVeno Medical Corp
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2019
- $31.2K
- Net income
- -$19.5M
- Total assets
- $29.6M
- Market cap
- $6.8M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $6.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 31, 2018
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review enVVeno Medical Corp.
